The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancerDevalingam Mahalingam, Steffan T. Nawrocki, Giovanni Selvaggi et al.|BMC Cancer|2015Cited by 19
Second-line treatment with nivolumab, cabozantinib, regorafenib, or best supportive care in patients with advanced hepatocellular carcinoma: analysis at a Hispanic-majority NCI-designated cancer centerJeffrey Xia, Sukeshi Patel Arora, Jonathan Gelfond|Journal of Gastrointestinal Oncology|2021Cited by 5
The efficacy and safety of sorafenib in older adults with advanced hepatocellular carcinoma: An analysis of a majority Hispanic cohortSukeshi Patel Arora, Devalingam Mahalingam, Snegha Ananth et al.|Journal of Geriatric Oncology|2020Cited by 3
GLP-1 receptor agonist vs aspirin for primary prevention of colorectal cancer: Evidence from a real-world head-to-head comparison.Colton Jones, Sukeshi Patel Arora, Elvis Obomanu et al.|Journal of Clinical Oncology|2026Cited by 3
Comparative efficacy and safety of sorafenib in elderly versus non-elderly patients with advanced hepatocellular carcinoma (HCC) with varying liver dysfunction.Sukeshi Patel Arora, Devalingam Mahalingam, Norma S. Ketchum et al.|Journal of Clinical Oncology|2018Cited by 2